Efficacy of vaccination against the SARS-CoV-2 virus in patients with chronic kidney disease on hemodialysis

Author:

Sanhueza María E.12ORCID,San Martín Pamela1ORCID,Brantes Loreto1,Caro Sylvia1,Carrasco Guillermo1,Machuca Eduardo1

Affiliation:

1. National Medical Directorate, NephroCare-Chile,Santiago, Chile

2. Nephrology DepartmentClinical Hospital, University of Chile, Santiago, Chile

Funder

reported

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference41 articles.

1. Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

2. Organización Mundial de la Salud. Neumonía de causa desconocida – China [Internet]. [accessed 2021 Dec 7]. https://www.who.int/es/emergencies/disease-outbreak-news/item/2020-DON229

3. World Health Organization. Novel coronavirus – China [Internet]. Novel Coronavirus – China. 2020 [accessed 2021 Dec 14]. https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON233

4. COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study

5. Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3